Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy.
Miguel Garcia-PardoKasia CzarneckaJennifer H LawAlexandra SalvarreyRoxanne FernandesJason FanLucy CorkeThomas K WaddellKazuhiro YasufukuLaura L DonahoeAndrew PierreLisa W LeNoor GhummanGeoffrey LiuFrances A ShepherdPenelope BradburyAdrian SacherTracy StockleyProdipto PalPatrik RogallaMing Sound TsaoNatasha B LeighlPublished in: Therapeutic advances in medical oncology (2022)
Liquid biopsy in the initial diagnostic workup of patients with suspected advanced NSCLC can lead to faster molecular results and shorten time to treatment even with smaller DNA panels. An expansion study using comprehensive NGS plasma testing with faster turnaround time is ongoing (NCT04862924).